Diagnosis of perioperative coagulopathy - Plasma versus whole blood testing

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 27, Issue 4 SUPPL., 2013, Pages S9-

  Tanaka, Kenichi A ^a   Bader, Stephen O ^a   Sturgil, Emily L ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

coagulopathy transfusion viscoelastic tests fibrinolysis platelet function tests

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE; ADENOSINE DIPHOSPHATE; APIXABAN; ARACHIDONIC ACID; BATROXOBIN; BLOOD CLOTTING FACTOR; CLOPIDOGREL; CYTOCHALASIN D; HEPARIN; KAOLIN; PROTAMINE; PYROPHOSPHATE; RIVAROXABAN; VITAMIN K GROUP;

ACUTE HEART INFARCTION; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; BRAIN ISCHEMIA; DIAGNOSTIC TEST; DRUG DOSE TITRATION; DRUG ELUTING STENT; ERYTHROCYTE; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; INTERMETHOD COMPARISON; LABORATORY TEST; PARTIAL THROMBOPLASTIN TIME; PLASMA; PLATELET REACTIVITY; PRIORITY JOURNAL; REACTION TIME; STENT THROMBOSIS; THERAPY; THROMBOCYTE FUNCTION; TURNAROUND TIME; VISCOELASTICITY;

COAGULOPATHY; FIBRINOLYSIS; PLATELET FUNCTION TESTS; TRANSFUSION; VISCOELASTIC TESTS;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; BLOOD LOSS, SURGICAL; BLOOD SPECIMEN COLLECTION; HEMOSTASIS, SURGICAL; HUMANS; PERIOPERATIVE CARE; THROMBELASTOGRAPHY;

EID: 84881161245     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2013.05.012     Document Type: Review

References (87)

1. G.J. Despotis, A.L. Summerfield, and J.H. Joist Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations J Thorac Cardiovasc Surg 108 1994 1076 1082
2. L. Shore-Lesserson, H. Manspeizer, and M. DePerio Thromboelastography- guided transfusion algorithm reduces transfusions in complex cardiac surgery Anesth Analg 88 1999 312 319
3. G.A. Nuttall, W.C. Oliver, and P.J. Santrach Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass Anesthesiology 94 2001 773 781
4. D. Royston, and S. von Kier Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass Br J Anaesth 86 2001 575 578
5. L. Capraro, A. Kuitunen, and M. Salmenpera On-site coagulation monitoring does not affect hemostatic outcome after cardiac surgery Acta Anaesthesiologica Scandinavica 45 2001 200 206
6. M. Avidan, E. Alcock, and J. Da Fonseca Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery Br J Anaesth 92 2004 178 186
7. E. Girdauskas, J. Kempfert, and T. Kuntze Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: A prospective, randomized trial J Thorac Cardiovasc Surg 140 2010 1117 1124
8. C.F. Weber, K. Gorlinger, and D. Meininger Point-of-care testing: A prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients Anesthesiology 117 2012 531 547
9. J.J. Como, R.P. Dutton, and T.M. Scalea Blood transfusion rates in the care of acute trauma Transfusion 44 2004 809 813
10. A. Levrat, A. Gros, and L. Rugeri Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients Br J Anaesth 100 2008 792 797
11. P. Toulon, Y. Ozier, and A. Ankri Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study Thromb Haemost 101 2009 394 401
12. R. Davenport, J. Manson, and H. De'Ath Functional definition and characterization of acute traumatic coagulopathy Crit Care Med 39 2011 2652 2658
13. J.B. Holcomb, C.E. Wade, and J.E. Michalek Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients Ann Surg 248 2008 447 458
14. A.M. Ho, P.W. Dion, and C.A. Cheng A mathematical model for fresh frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage Can J Surg 48 2005 470 478
15. P. Chowdhury, A.G. Saayman, and U. Paulus Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients Br J Haematol 125 2004 69 73
16. C. Narick, D.J. Triulzi, and M.H. Yazer Transfusion-associated circulatory overload after plasma transfusion Transfusion 52 2012 160 165
17. A.M. Ho, P.W. Dion, and J.H. Yeung Prevalence of survivor bias in observational studies on fresh frozen plasma: Erythrocyte ratios in trauma requiring massive transfusion Anesthesiology 116 2012 716 728
18. M.C. Engoren, R.H. Habib, and A. Zacharias Effect of blood transfusion on long-term survival after cardiac operation Ann Thorac Surg 74 2002 1180 1186
19. C.G. Koch, L. Li, and D.I. Sessler Duration of red-cell storage and complications after cardiac surgery N Engl J Med 358 2008 1229 1239
20. G.A. Watson, J.L. Sperry, and M.R. Rosengart Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome J Trauma 67 2009 221 227
21. S. Ogawa, J.E. Richardson, and T. Sakai High mortality associated with intracardiac and intrapulmonary thromboses after cardiopulmonary bypass J Anesth 26 2012 9 19
22. S. Zou, F. Musavi, and E.P. Notari Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008 Transfusion 50 2010 1487 1494
23. W.L. Chandler, C. Ferrell, and S. Trimble Development of a rapid emergency hemorrhage panel Transfusion 50 2010 2547 2552
24. Segal JB, Dzik WH: Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: An evidence-based review. Transfusion 45:1413-1425, 2005.
25. K.A. Tanaka, N.S. Key, and J.H. Levy Blood coagulation: Hemostasis and thrombin regulation Anesth Analg 108 2009 1433 1446
26. P. Toulon, C. Lecourvoisier, and O. Meyniard Evaluation of a rapid qualitative immuno-chromatography D-dimer assay (Simplify D-dimer) for the exclusion of pulmonary embolism in symptomatic outpatients with a low and intermediate pretest probability. Comparison with two automated quantitative assays Thromb Res 123 2009 543 549
27. T. Lang, and M. von Depka Possibilities and limitations of thromboelastometry/thromboelastography Hämostaseologie 26 2006 S21 S29
28. D. Bolliger, M.D. Seeberger, and K.A. Tanaka Principles and practice of thromboelastography in clinical coagulation management and transfusion practice Transfus Med Rev 26 2012 1 13
29. K.A. Tanaka, D. Bolliger, and R. Vadlamudi Rotational Thromboelastometry (ROTEM)-based coagulation management in cardiac surgery and major trauma J Cardiothorac Vasc Anesth 26 2012 1083 1093
30. M.T. Ganter, and C.K. Hofer Coagulation monitoring: Current techniques and clinical use of viscoelastic point-of-care coagulation devices Anesth Analg 106 2008 1366 1375
31. R.J. Luddington Thrombelastography/thromboelastometry Clin Lab Haematol 27 2005 81 90
32. C. Solomon, B. Sorensen, and G. Hochleitner Comparison of whole blood fibrin-based clot tests in thrombelastography and thromboelastometry Anesth Analg 114 2012 721 730
33. T. Lang, A. Bauters, and S.L. Braun Multi-centre investigation on reference ranges for ROTEM thromboelastometry Blood Coagul Fibrinolysis 16 2005 301 310
34. M. Coakley, K. Reddy, and I. Mackie Transfusion triggers in orthotopic liver transplantation: A comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests J Cardiothorac Vasc Anesth 20 2006 548 553
35. T. Tomori, D. Hupalo, and K. Teranishi Evaluation of coagulation stages of hemorrhaged swine: Comparison of thromboelastography and rotational elastometry Blood Coagul Fibrinolysis 21 2010 20 27
36. L.F. Venema, W.J. Post, and H.G. Hendriks An assessment of clinical interchangeability of TEG and RoTEM thromboelastographic variables in cardiac surgical patients Anesth Analg 111 2010 339 344
37. O.H. Larsen, C. Fenger-Eriksen, and K. Christiansen Diagnostic performance and therapeutic consequence of thromboelastometry activated by kaolin versus a panel of specific reagents Anesthesiology 115 2011 294 302
38. S.T. Hiippala, G.J. Myllyla, and E.M. Vahtera Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates Anesth Analg 81 1995 360 365
39. D. Bolliger, K. Gorlinger, and K.A. Tanaka Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution Anesthesiology 113 2010 1205 1219
40. C. Fenger-Eriksen, G.W. Moore, and S. Rangarajan Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders Transfusion 50 2010 2571 2576
41. L. Rugeri, A. Levrat, and J.S. David Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography J Thromb Haemost 5 2007 289 295
42. S. Ogawa, F. Szlam, and E.P. Chen A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery Transfusion 52 2012 14 22
43. S. Roullet, J. Pillot, and G. Freyburger Rotation thromboelastometry detects thrombocytopenia and hypofibrinogenaemia during orthotopic liver transplantation Br J Anaesth 104 2010 422 428
44. S. Ogawa, F. Szlam, and D. Bolliger The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry Anesth Analg 115 2012 16 21
45. S. Moganasundram, B.J. Hunt, and K. Sykes The relationship among thromboelastography, hemostatic variables, and bleeding after cardiopulmonary bypass surgery in children Anesth Analg 110 2010 995 1002
46. B. Nascimento, M. Al Mahoos, and J. Callum Vitamin K-dependent coagulation factor deficiency in trauma: A comparative analysis between international normalized ratio and thromboelastography Transfusion 52 2012 7 13
47. S. Yuan, C. Ferrell, and W.L. Chandler Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma Thromb Res 120 2007 29 37
48. F. Szlam, G. Sreeram, and C. Solomon Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux Thromb Res 127 2011 135 140
49. C.F. Weber, K. Gorlinger, and D. Meininger Point-of-care testing: A prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients Anesthesiology 117 2012 531 547
50. D. Bolliger, F. Szlam, and J.H. Levy Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: Implications for early haemostatic intervention in massive haemorrhage Br J Anaesth 104 2010 318 325
51. H. Schochl, T. Frietsch, and M. Pavelka Hyperfibrinolysis after major trauma: Differential diagnosis of lysis patterns and prognostic value of thrombelastometry J Trauma 67 2009 125 131
52. J.L. Kashuk, E.E. Moore, and M. Sawyer Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma Ann Surg 252 2010 434 442
53. H. Shakur, I. Roberts, and R. Bautista Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial Lancet 376 2010 23 32
54. T. Taketomi, F. Szlam, and J.H. Levy Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII Blood Coagul Fibrinolysis 19 2008 106 108
55. D. Bolliger, F. Szlam, and R.J. Molinaro Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: An in vitro model Br J Anaesth 102 2009 793 799
56. D. Dirkmann, K. Gorlinger, and C. Gisbertz Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood Anesth Analg 114 2012 1182 1188
57. W.A. Khaja, O. Bilen, and R.B. Lukner Evaluation of heparin assay for coagulation management in newborns undergoing ECMO Am J Clin Pathol 134 2010 950 954
58. O. Shigeta, H. Kojima, and Y. Hiramatsu Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass J Thorac Cardiovasc Surg 118 1999 354 360
59. G.J. Despotis, J.H. Joist, and C.W. Hogue Jr The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation J Thorac Cardiovasc Surg 110 1995 46 54
60. N.A. Guzzetta, H.G. Monitz, and J.D. Fernandez Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass Anesth Analg 111 2010 173 179
61. S.A. Harding, S.V. Mallett, and T.D. Peachey Use of heparinase modified thrombelastography in liver transplantation Br J Anaesth 78 1997 175 179
62. M. Mittermayr, J. Margreiter, and C. Velik-Salchner Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem): An in vitro study Br J Anaesth 95 2005 310 316
63. M. Mittermayr, C. Velik-Salchner, and B. Stalzer Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): Results of a pilot study Anesth Analg 108 2009 743 750
64. T. Lang, W. Toller, and M. Gutl Different effects of abciximab and cytochalasin D on clot strength in thrombelastography J Thromb Haemost 2 2004 147 153
65. U.S. Tantry, K.P. Bliden, and P.A. Gurbel Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation J Am Coll Cardiol 46 2005 1705 1709
66. E. Mahla, T.A. Suarez, and K.P. Bliden Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: The timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study Circ Cardiovasc Interv 5 2012 261 269
67. N.J. Breet, J.W. van Werkum, and H.J. Bouman Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
68. H.T. Benzon, R.J. McCarthy, and H.A. Benzon Determination of residual antiplatelet activity of clopidogrel before neuraxial injections Br J Anaesth 107 2011 966 971
69. M.M. Samama, J.L. Martinoli, and L. LeFlem Assessment of laboratory assays to measure rivaroxaban - an oral, direct factor Xa inhibitor Thromb Haemost 103 2010 815 825
70. A. Godier, A. Miclot, and B. Le Bonniec Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model Anesthesiology 116 2012 94 102
71. J. van Ryn, J. Stangier, and S. Haertter Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity Thromb Haemost 103 2010 1116 1127
72. A. Koster, D. Chew, and M. Grundel Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass Anesth Analg 96 2003 383 386
73. C Sucker, RB Zotz, and K Gorlinger Rotational thrombelastometry for the bedside monitoring of recombinant hirudin Acta Anaesthesiol Scand 52 2008 358 362
74. T. Taketomi, F. Szlam, and J. Vinten-Johansen Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors Blood Coagul Fibrinolysis 18 2007 761 767
75. G. Young, K.E. Yonekawa, and P.A. Nakagawa Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation Blood Coagul Fibrinolysis 18 2007 97 103
76. R.J. Molinaro, F. Szlam, and J.H. Levy Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin Anesthesiology 109 2008 160 161
77. K.A. Tanaka, F. Szlam, and K. Koyama Argatroban "reversal" is caused by nonphysiologic stimulation of coagulation, not activated factor VII J Cardiothorac Vasc Anesth 24 2010 1026 1027
78. J.L. Kashuk, E.E. Moore, and A. Sabel Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients Surgery 146 2009 764 772
79. M.S. Park, W.Z. Martini, and M.A. Dubick Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time J Trauma 67 2009 266 275
80. G.M. Rodgers Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update Thromb Haemost 101 2009 806 812
81. B.S. Donahue Factor V Leiden and perioperative risk Anesth Analg 98 2004 1623 1634
82. T. Baglin, E. Gray, and M. Greaves Clinical guidelines for testing for heritable thrombophilia Br J Haematol 149 2010 209 220
83. T.G. DeLoughery Logistics of massive transfusions Hematology Am Soc Hematol Educ Program 2010 2010 470 473
84. J.H. Levy, K.A. Tanaka, and W. Dietrich Perioperative hemostatic management of patients treated with vitamin K antagonists Anesthesiology 109 2008 918 926
85. J.H. Levy, F. Szlam, and K.A. Tanaka Fibrinogen and hemostasis: A primary hemostatic target for the management of acquired bleeding Anesth Analg 114 2012 261 274
86. F. Dentali, C. Marchesi, and M.G. Pierfranceschi Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis Thromb Haemost 106 2011 429 438
87. W. Miesbach, and E. Seifried New direct oral anticoagulants - current therapeutic options and treatment recommendations for bleeding complications Thromb Haemost 108 2012 625 632